Director/PDMR Shareholding

RNS Number : 8804F

GlaxoSmithKline PLC

01 August 2016

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms C Thomas
b)	Position/status	Senior Vice President, Human Resources
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The exercise of options over 20,180 Ordinary Shares, granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £11.47 20,180
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2016-07-28
f)	Place of the transaction	n/a

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms C Thomas
b)	Position/status	Senior Vice President, Human Resources
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Sale of 17,024 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 20,180 Ordinary Shares granted on 19 February 2008 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £17.0778 17,024
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2016-07-28
f)	Place of the transaction	London Stock Exchange (XLON)

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms C Thomas
b)	Position/status	Senior Vice President, Human Resources
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	The exercise of options over 20,180 Ordinary Shares, granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £14.88 20,180
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2016-07-28
f)	Place of the transaction	n/a

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Ms C Thomas
b)	Position/status	Senior Vice President, Human Resources
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial  instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Sale of 19,235 Ordinary Shares to satisfy option costs and the tax and NI liability arising following the exercise of options over 20,180 Ordinary Shares granted on 20 February 2007 under the GlaxoSmithKline Share Option Plan.
c)	Price(s) and volume(s)	Price(s) Volume(s) £17.0814 19,235
d)	Aggregated information Aggregated volume Price	n/a (single transaction)
e)	Date of the transaction	2016-07-28
f)	Place of the transaction	London Stock Exchange (XLON)

 

END

 

 

DSHZFLFBQVFLBBB